BMS To Take Over Novartis Plant In Effort To Boost Viral Vector Production For CAR-Ts

BMS said it would take control of a Novartis plant in Illinois to manufacture viral vectors for CAR-T • Source: Shutterstock

More from Immuno-oncology

More from Anticancer